New White House rule would make weight loss drugs available for people on Medicare and Medicaid

Biden proposes Medicare and Medicaid cover weight-loss drugs for 7.4m people

Move aims to tackle US’s chronic obesity problem, but poses a challenge to Trump’s incoming administration. The Biden administration is proposing to make “miracle” weight loss drugs free for ...

World - The Guardian - 3 days ago

Biden proposes weight loss drug coverage requirements for Medicare and Medicaid

Weight loss drugs like Wegovy, Zepbound and Ozempic would be covered by Medicare and Medicaid under a Biden administration proposal.

Biden proposes Medicare and Medicaid cover weight-loss drugs for obese Americans

Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday ...

Health - ABC News - 3 days ago

Biden proposes expanded coverage for weight loss drugs under Medicare, Medicaid

The Biden administration has proposed a plan for Medicare and Medicaid to offer coverage for weight loss medications, such as Ozempic and Wegovy.

Politics - NBC News - 3 days ago

Biden proposes weight loss drug coverage by Medicare, Medicaid

President Biden's proposal for Medicaid and Medicare coverage for weight loss drugs such as Ozempic and Wegovy could draw opposition from the drug industry and President-elect Donald Trump's ...

Top stories - CBS News - 3 days ago

Why Biden is proposing weight loss drug Medicare, Medicaid coverage

President Biden's proposal to expand Medicaid and Medicare coverage for some weight loss drugs could impact thousands of Americans. CBS News' Alexander Tin breaks down what's known about the ...

Top stories - CBS News - 3 days ago

Biden seeks Medicare and Medicaid coverage of popular but costly weight-loss drugs for millions of Americans

Health - ABC News - 3 days ago

Biden’s plan for Medicare coverage of weight-loss drugs would drive up costs by billions of dollars

The plan would need to be supported by the incoming Trump administration, which has vowed to cut costs across the federal government.

Business - MarketWatch - 2 days ago

Obesity Drugs Would Be Covered by Medicare and Medicaid Under Biden Proposal

The proposed rule could give millions of Americans access to the new drugs; it will also put pressure on the incoming Trump administration.

Top stories - The New York Times - 3 days ago

Who gets weight loss drugs covered by insurance? In North Carolina, being on Medicaid helps.

North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended coverage for Medicaid recipients.

Biden proposes Medicare, Medicaid coverage of obesity drugs

The Biden administration proposed a new rule Tuesday that would allow anti-obesity drugs like Wegovy and Zepbound to be covered under Medicaid and Medicare for more Americans. Millions of Americans ...

Politics - The Hill - 3 days ago

New Obesity Drug MariTide Helps Patients Lose Up to 20% of Weight, Early Data Shows

The drug, which is named MariTide and delivered in a monthly injection, is some time away from being sold.

Business - The New York Times - 3 days ago

Biden wants drugs like Wegovy, Ozempic covered by Medicare, Medicaid

Millions of Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare and Medicaid under a rule the Biden administration has proposed.

Top stories - CBS News - 3 days ago

Biden proposes expanding obesity drug coverage under Medicare and Medicaid

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans with Medicare and Medicaid.

Nurse’s death linked to approved weight-loss drug

Susan McGowan from North Lanarkshire died two weeks after taking the drug tirzepatide, brand name Mounjaro.

Weight-loss-drug makers’ stocks get a boost from new Biden coverage proposal, but will it hold up?

The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board early Tuesday, after the Biden administration proposed a rule that would ...

Business - MarketWatch - 3 days ago

Weight loss drug industry injects wealth into Novo Nordisk home country

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great heft to the economy of Novo Nordisk's home country, Denmark.

Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial

The stock, which enjoys the unusual position of having all buy ratings from the 13 analysts offering coverage on FactSet, has been on a tear this year, gaining 270% to date in 2024.

Business - MarketWatch - November 4

Counterfeit weight loss drugs sold online as demand for cheaper options grows

A surge in counterfeit versions of popular weight loss drugs is raising health concerns. U.S. Customs is intercepting fake medications with potentially harmful effects. Tom Hanson reports on the ...

Counterfeit weight loss drugs feed demand for cheaper options

Record demand for Ozempic, Wegovy and other weight loss drugs is fueling a surge of dangerous knockoffs.

Ozempic, Wegovy popularity leads to rise of fake weight loss drugs

The demand for weight loss drugs like Ozempic and Wegovy has led to a flood of fake drugs hitting the market. However, these counterfeit medicines can be harmful to people's health. Tom Hanson has ...

Surging diabetes rate underscores vast opportunity in weight-loss drugs

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according to new data released in The Lancet on World Diabetes Day.

Business - MarketWatch - November 14

RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply lower Friday, after President-elect Donald Trump named Robert F. Kennedy ...

Business - MarketWatch - November 16

Employers Get Pressure to Pay for Drugs Like Wegovy

Eli Lilly and Novo Nordisk representatives get face time with companies in hopes they will cover their weight-loss drugs.

Business - The Wall Street Journal - November 19

Novo Nordisk Launches Wegovy Weight-Loss Drug in China

The first prescription for the drug in China will reportedly be issued at a public hospital in Shanghai this week and will cost about $193 for a one-month supply of the lowest starter dose.

Business - The Wall Street Journal - November 19

More Large U.S. Employer Health Plans Covering Weight-Loss Drugs

A survey by consulting firm Mercer shows that close to half of U.S. companies with more than 500 employees now cover drugs such as Wegovy, Ozempic, and Zepbound.

Business - Inc. - November 20

Weight-loss drugs can improve kidney health, study finds

Analysis involving more than 85,000 people showed risk of worsening function was reduced by 22%. Weight-loss drugs can reduce the risk of worsening kidney function, kidney failure and dying from ...

World - The Guardian - 4 days ago

Biden proposes huge expansion of US weight-loss drug coverage

State-backed insurance programmes would fund drugs for obese patients without separate health conditions

World - Financial Times - 3 days ago

Why Thanksgiving may feel different for Americans on weight loss drugs

This may be the first Thanksgiving for millions of Americans who are on GLP-1 agonists like Ozempic, Zepbound or Wegovy.

Top stories - CBS News - 3 days ago

Even with access to blockbuster obesity drugs, some people don't lose weight

Most people taking popular drugs like Ozempic and Wegovy to lose weight have shed significant pounds

Health - ABC News - 6 days ago

Amgen says no concerns around weight loss drug’s bone density data after stock falls

Analysts chewed over early data showing the highest dose of Amgen's MariTide was linked to roughly 4% loss of bone mineral density over 12 weeks.

Business - CNBC - November 13

Venom Helped Create Weight-Loss Drugs. What Else Could It Do For Us?

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the beginning.

Science - The New York Times - November 14

New White House rule would make weight loss drugs available for people on Medicare and Medicaid

Topics